Baorentang
Latest round
- Series B
Last raised
- Dec 2025
Total raised
- Undisclosed
Investors
- 1
About Baorentang
, trading as Baorentang, engages in drug research and development, drug manufacturing, and contract manufacturing, striving to meet market demands. The company's core product, "Sanbei Zhuhan Capsules," a national Class 1 innovative traditional Chinese medicine, has currently entered the new drug approval stage. The company generates revenue by manufacturing and selling proprietary medicines and other related products.
Who invested in Baorentang
1 investor across 1 round
See all investors in Baorentang
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Dec 30, 2025
Amount
Undisclosed
Investors
Questions about Baorentang
Who invested in Baorentang?
Baorentang has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Baorentang raised?
Baorentang has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Baorentang last raise money?
Baorentang's most recent round on record is a Series B, in Dec 2025.
What does Baorentang do?
, trading as Baorentang, engages in drug research and development, drug manufacturing, and contract manufacturing, striving to meet market demands.
Where is Baorentang headquartered?
Baorentang is headquartered in Hangzhou, China.
Which VCs invest in companies like Baorentang?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Baorentang's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Baorentang? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.